AmpliPhi Biosciences Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Armata Pharmaceuticals, based in Marina Del Rey, California, operates in the biotechnology research field with a focus on bacteriophage therapies aimed at combating antimicrobial-resistant infections. It was formed by the collaboration of seasoned drug development teams from AmpliPhi Biosciences Corporation and C3J Therapeutics. It positions itself as a developer of high-impact, best-in-class phage therapies intended to address serious bacterial threats. 
Armata is advancing a pipeline of natural and synthetic phage candidates, including programs targeting Pseudomonas aeruginosa, Staphylococcus aureus, and other clinically important pathogens. One lead asset, AP-PA02, is being developed as a potential treatment for chronic respiratory infections caused by P. aeruginosa in people with cystic fibrosis and non-cystic fibrosis bronchiectasis. The company is listed on the NYSE American exchange under the ticker ARMP.

Get verified AmpliPhi Biosciences emails free

Company overview Employee directory